Novartis Ag ADR (NVS)
111.98 x 1 116.00 x 1
Post-market by (Cboe BZX)
112.57 +1.17 (+1.05%) 03/28/25 [NYSE]
111.98 x 1 116.00 x 1
Post-market 112.75 +0.18 (+0.16%) 18:30 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,939,000 | 8,572,000 | 6,049,000 | 24,018,000 | 8,071,000 |
| Depreciation Amortization | 6,114,000 | 8,383,000 | 6,965,000 | N/A | 6,129,000 |
| Income taxes - deferred | 1,701,000 | 551,000 | 1,128,000 | N/A | 1,807,000 |
| Accounts receivable | -931,000 | -1,504,000 | N/A | -389,000 | 137,000 |
| Accounts payable and accrued liabilities | -105,000 | 479,000 | N/A | -21,000 | -324,000 |
| Other Working Capital | -706,000 | -369,000 | -796,000 | 241,000 | -291,000 |
| Other Operating Activity | -393,000 | -1,654,000 | 890,000 | -8,778,000 | -1,879,000 |
| Operating Cash Flow | $17,619,000 | $14,458,000 | $14,236,000 | $15,071,000 | $13,650,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -711,000 | 10,607,000 | 4,662,000 | -14,105,000 | -1,408,000 |
| PPE Investments | -1,280,000 | -823,000 | -758,000 | -1,138,000 | -1,187,000 |
| Net Acquisitions | -3,911,000 | -4,681,000 | -1,276,000 | 20,102,000 | -10,091,000 |
| Purchase Of Investment | -203,000 | -117,000 | -139,000 | -191,000 | -230,000 |
| Sale Of Investment | 957,000 | 348,000 | 133,000 | 442,000 | 723,000 |
| Purchase Sale Intangibles | -2,368,000 | 262,000 | -1,153,000 | -845,000 | -930,000 |
| Other Investing Activity | -2,365,000 | 262,000 | -1,154,000 | -902,000 | -989,000 |
| Investing Cash Flow | $-7,513,000 | $5,596,000 | $1,468,000 | $4,208,000 | $-13,182,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 958,000 | 546,000 | 252,000 | -3,524,000 | 2,261,000 |
| Debt Issued | 6,143,000 | N/A | N/A | 16,000 | 7,126,000 |
| Debt Repayment | -2,160,000 | -2,223,000 | -2,575,000 | -2,162,000 | -2,003,000 |
| Common Stock Issued | 30,000 | 153,000 | 100,000 | 53,000 | N/A |
| Common Stock Repurchased | -8,331,000 | -8,719,000 | -10,652,000 | -3,057,000 | -2,842,000 |
| Dividend Paid | -7,624,000 | -7,255,000 | -7,506,000 | -7,368,000 | -6,987,000 |
| Other Financing Activity | -758,000 | 3,220,000 | -181,000 | -222,000 | 237,000 |
| Financing Cash Flow | $-11,742,000 | $-14,278,000 | $-20,562,000 | $-16,264,000 | $-2,208,000 |
| Exchange Rate Effect | -298,000 | 100,000 | -32,000 | -266,000 | 286,000 |
| Beginning Cash Position | 13,393,000 | 7,517,000 | 12,407,000 | 9,658,000 | 11,112,000 |
| End Cash Position | 11,459,000 | 13,393,000 | 7,517,000 | 12,407,000 | 9,658,000 |
| Net Cash Flow | $-1,934,000 | $5,876,000 | $-4,890,000 | $2,749,000 | $-1,454,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,619,000 | 14,458,000 | 14,236,000 | 15,071,000 | 13,650,000 |
| Capital Expenditure | -1,366,000 | -1,060,000 | -916,000 | -1,378,000 | -1,275,000 |
| Free Cash Flow | 16,253,000 | 13,398,000 | 13,320,000 | 13,693,000 | 12,375,000 |